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the Frailty or the Heart Disease?
Exploring the Vicious Cycle*Kelsey Flint, MDSEE PAGE 976F railty is the accumulation of subclinical physi-ologic insults across multiple organ systems,leading to a state of heightened vulnerability
in the face of stress. Although initially conceived of
as a geriatric syndrome most applicable in the pri-
mary care setting, over the past decade frailty has
been applied to a variety of settings, including medi-
cally and surgically treated cardiovascular disease
(CVD). The adverse outcomes associated with frailty
and CVD are clearly demonstrated in the existing
literature (1); however, little is known regarding
the biological underpinnings of this association or
whether the progression of one disease state affects
the other. Furthermore, it is not known if frailty is
reversible and, if so, what might be the optimal
timing and composition of frailty treatments aimed
at improving cardiovascular outcomes.
Understanding the relationship between frailty and
CVD remains challenging, because the end result of
both entities may clinically appear very similar. One
approach to understanding this relationship is to
address the age-old chicken-or-the-egg question,
“Which came ﬁrst?” That is, does frailty develop ﬁrst,
thus contributing to the development of CVD? Or does
existing CVD lead to frailty? Determining if one disease
state precipitates the other holds signiﬁcant implica-
tions for designing interventions aimed at improving
the plight of older adults suffering from both frailty
and CVD.*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
From the University of Colorado School of Medicine, Division of Cardi-
ology, Aurora, Colorado. Dr. Flint has reported that she has no relation-
ships relevant to the contents of this paper to disclose.In this issue of the Journal, Sergi et al. (2) tested the
ﬁrst of these hypotheses in a prospective study of
1,567 older adults without frailty or CVD at baseline.The authors report the association of pre-frailty at
study entry with the development of CVD over a
4.4-year follow-up period. Frailty was measured
using modiﬁed Fried criteria: slow gait speed, weak
grip strength, low energy expenditure, exhaustion,
and unintentional weight loss; several of the original
Fried criteria (3) were modiﬁed to match the data
available in the study. Pre-frailty was deﬁned as the
presence of 1 or 2 criteria, whereas frailty was deﬁned
as the presence of 3 or more. The combined primary
endpoint consisted of incident coronary artery dis-
ease, peripheral artery disease, heart failure, stroke,
and death from a cardiovascular cause. Physicians
conﬁrmed new cardiovascular diagnoses at study
visits and deaths were adjudicated via death certiﬁ-
cate review. The authors found that those with
pre-frailty at baseline suffered an increased risk of
incident CVD or death compared with their robust
counterparts (i.e., met no modiﬁed Fried criteria).
The association was stronger for those who met 2
modiﬁed Fried criteria rather than 1 and was inde-
pendent of numerous traditional risk factors.
This study supports the hypothesis that frailty
contributes to the subsequent development of CVD by
demonstrating that patients are at increased risk for
incident CVD even before the full frailty phenotype
manifests. Interestingly, several subclinical insults
existed in the pre-frail, but not robust, patients
at study entry. For example, hemoglobin A1c was
signiﬁcantly higher in patients meeting 1 or 2 modi-
ﬁed Fried criteria compared with those meeting
0 criteria; although not diagnostic of diabetes, this
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985relatively higher hemoglobin A1c in pre-frail patients
suggests that they may have subclinical insulin
resistance not present in their robust counterparts. A
similar trend was seen with white blood cell count,
erythrocyte sedimentation rate, uric acid, and vitamin
D levels as well as ankle brachial index and waist
circumference. These subclinical changes were more
pronounced in patients meeting 2 modiﬁed Fried
criteria versus 1, and those meeting 1 such criterion
versus none. The accumulation of these subclinical
insults may manifest as pre-frailty, which, in conjunc-
tion with other comorbid conditions and advanced
chronological age, likely increases risk for CVD.
Existing data suggest that the reverse is also true:
clinical and subclinical CVD are associated with an
increased risk of frailty (4–6). Interestingly, the cur-
rent study does hold clues to support the existence of
a bidirectional relationship, because pre-frail patients
had lower ankle brachial index and higher prevalence
of atrial ﬁbrillation compared with robust patients.
Furthermore, of the 5 modiﬁed Fried criteria studied,
low energy expenditure was most strongly associated
with the primary outcome. Sedentary lifestyle is a
well-known risk factor for CVD; therefore, this ﬁnding
may represent a common pathway through which the
2 distinct entities develop.
The evidence supporting a bidirectional causal
relationship between frailty and CVD helps describe
these 2 disease states as a vicious cycle, with the
presence of one feeding the development of the
other. The results from Sergi et al. (2) suggest that any
intervention aimed at breaking this vicious cycle may
be successful by targeting patients earlier in the
disease course (i.e., patients with pre-frailty or
subclinical CVD). Interventions more likely to break
the vicious cycle between frailty and CVD may be
those designed to augment overall physiologic
reserve and address vulnerabilities speciﬁc to CVD
risk. As suggested in the authors’ central illustra-
tion, global physiologic reserve may be augmented
through multidimensional assessments designed to
identify and treat problems most likely to contribute
to pre-frailty. Clinicians should pay speciﬁc attention
to geriatric syndromes, such as polypharmacy and
poor nutrition, while ensuring patients’ other medical
illnesses are optimally managed. Indeed, it makes
biological and clinical sense that patients whose
comorbidities are well cared for will be less likely
to develop pre-frailty. Although other potential
targets for augmenting global physiologic reserve are
the subclinical changes associated with pre-frailty,
designing interventions likely to demonstrate mea-
surable improvement in CVD risk will be difﬁcult
given the small absolute differences between robustand pre-frail patients and the heterogeneity of sub-
clinical insults that contribute to pre-frailty.
CVD risk factors are more prevalent in frail
compared with nonfrail patients (4,5,7); therefore, an
important component to breaking the vicious cycle
may lie in aggressive cardiovascular risk factor man-
agement. Indeed, treatments aimed at improving low
energy expenditure (the modiﬁed Fried criterion most
strongly associated with incident CVD in this study)
may be instrumental in treating both pre-frailty and
preventing CVD. If such treatments are successful,
determining whether the positive effects are medi-
ated primarily through preventing CVD versus re-
versing pre-frailty will require careful study design.
Although Sergi et al. (2) provide many excellent
insights into the complex relationship between frailty
and CVD, their study must be interpreted with care.
The authors aimed to enroll patients free from CVD at
baseline; however, they did include patients with
atrial ﬁbrillation. Unfortunately, the authors did not
undertake an exhaustive search for subclinical CVD at
study entry. As a result, they do not address the
possibility of subclinical atherosclerosis or structural
heart disease contributing to the development of pre-
frailty and subsequent CVD. The authors attempted to
replicate the original Fried criteria (arguably the most
widely recognized frailty deﬁnition) but had to make
modiﬁcations on the basis of the data available in
their population. Given these limitations, the insights
gleaned from this study must be conﬁrmed and built
upon in large, longitudinal cohorts in whom both
subclinical CVD and frailty status are clearly delin-
eated at baseline and closely followed over time.
The existing literature increasingly characterizes
frailty and CVD as intertwined processes that exac-
erbate one another in a vicious cycle leading to poor
outcomes. The results from Sergi et al. (2) suggest
that this vicious cycle has its roots long before either
frailty or CVD clinically manifest. For now, it seems
that the causal relationship between frailty and CVD
remains as circular as the question of whether the
chicken or the egg came ﬁrst. Thus, to advance the
study of frailty and CVD to the next level, clinicians
and researchers must meticulously study the mecha-
nisms behind their link, and rigorously test treatments
aimed at mitigating the adverse consequences asso-
ciated with clinical and subclinical frailty and CVD.
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